ABBS博客分享 自由的小鱼


ABBS: HMGB2 in pancreatic cancer

已有 787 次阅读 2018-9-19 10:46 |个人分类:期刊新闻|系统分类:论文交流

Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer

Xin Cai , Hongjian Ding , Yanxia Liu , Gaofeng Pan , Qingguo Li Zhen Yang, and Weiyan Liu

Department of General Surgery, Fudan University, Minhang Hospital, Shanghai 201199, China

Acta Biochim Biophys Sin 2017, 49: 119–127; doi: 10.1093/abbs/gmw124

High mobility group proteins (HMGs) are the second most abundant chromatin proteins and exert global genomic functions in the establishment of active or inactive chromatin domains. Through interaction with nucleosomes, transcription factors, nucleosome-remodeling machines and histones, the HMGs family proteins contribute to the fine tuning of transcription in response to rapid environmental changes. Mammalian high mobility group Bs (HMGBs) are characterized by two tandem HMG box domains followed by a long acidic tail. Recent studies demonstrated that high expression of HMGBs has been found in many cancers, such as prostate, kidney, ovarian, and gastric cancers. However, their roles in pancreatic cancer have seldom been reported. In this study, we assessed the diagnostic and prognostic values of HMGBs proteins, including HMGB1, HMGB2, and HMGB3, in pancreatic cancer from the Cancer Genome Atlas (TCGA) dataset. Our results demonstrated that HMGB2 predicted poor prognosis in pancreatic cancer. In vitro studies demonstrated that silencing HMGB2 inhibited cell proliferation and viability. Mechanistically, our results demonstrated that silencing HMGB2 decreased hypoxia inducible factor 1α (HIF1α) protein level and inhibited HIF1α-mediated glycolysis process. Further analysis indicated that HIF1α-targeted glycolytic genes, including GLUT1, HK2, and LDHA, are all prognostic factors and positively correlated with HMGB2 expression. Taken together, we discovered new prognostic and predictive markers for pancreatic cancer, and shed light on the novel function of HMGB2 in glycolytic control in cancer.


Silencing HMGB2 inhibits cell proliferation & HMGB2 modulates AKT/mTOR/HIF1α




1 HMGB2 is associated with malignancy and regulates Warburg effect by targeting LDHB and FBP1 in breast cancer

Long non-coding RNA MALAT1 drives gastric cancer progression by regulating HMGB2 modulating the miR-1297

miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2

A small molecule binding HMGB1 and HMGB2 inhibits microglia-mediated neuroinflammation

HMGB1 in health and disease

Novel role of PKR in inflammasome activation and HMGB1 release

Neurogenic to Gliogenic Fate Transition Perturbed by Loss of HMGB2



上一篇:ABBS: GPx1 benefits chondrogenic differentiation
下一篇:ABBS: Squalene epoxidase induces EMT through miR-133b


该博文允许注册用户评论 请点击登录 评论 (0 个评论)


Archiver|手机版|科学网 ( 京ICP备14006957 )

GMT+8, 2019-12-15 20:50

Powered by

Copyright © 2007- 中国科学报社